New Delhi9 minutes ago
- copy link
AIIMS Delhi did research on 63 breakthrough infected people in its study. In this, there were 36 patients who had taken both doses of the vaccine, while 27 had only one dose.
All India Institute of Medical Science (AIIMS) Delhi conducted a study among Corona, in which a good news has come out. The AIIMS study has claimed that not a single person has died of corona after applying the vaccine. He did this study during April-May, when the second wave of corona was at its peak and thousands of people lost their lives.
If corona occurs after vaccination, it is called a breakthrough infection. The study of AIIMS Delhi is also a relief news for those who are afraid of getting the vaccine. Such cases are seen especially in villages. There are many people in the city too, who are afraid of getting the vaccine. After the study, they should understand that the vaccine is the only way to avoid corona.
Research was done on 63 breakthrough infected people
AIIMS Delhi did research on 63 breakthrough infected people in its study. In this, there were 36 patients who had taken both doses of the vaccine, while 27 had only one dose. Of these, 10 people had Coveshield and 53 people had Covaxin. Patients aged 21 to 92 years were included in this study. The average age of all was 37. Of the 63 patients, 41 were men and 22 were women.
An American research found that most patients who got infected after getting the vaccine were cured at home. While there have been very few such patients who have had to be admitted to the hospital due to severe symptoms. However, no one has died in either case.
1.80 people died due to delta variant of corona in india
The second wave in India started on 11 February and turned catastrophic in April. In a study, a variant of Corona has been found in the country, Delta Super Infectious, which spread very rapidly during the second wave. It has killed more than 1.80 lakh people in India. Is the antibody or vaccine effective against this variant? Don’t know this for sure.
WHO says that the effectiveness of the vaccine on the delta variant, can not say anything on how effective the drugs are. It is also not known how much risk of reinfection is due to this. Preliminary results say that the effectiveness of a monoclonal antibody used in the treatment of Kovid-19 has decreased.